Surfactant protein D is proatherogenic in mice

Grith L. Sorensen, Jens Madsen, Karin Kejling, Ida Tornoe, Ole Nielsen, Paul Townsend, Francis R Poulain, Claus H. Nielsen, Kenneth B M Reid, Samuel Hawgood, Erling Falk, Uffe Holmskov

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Surfactant protein D (SP-D) is an important innate immune defense molecule that mediates clearance of pathogens and modulates the inflammatory response. Moreover, SP-D is involved in lipid homeostasis, and pulmonary accumulation of phospholipids has previously been observed in SP-D-deficient (Spd-/-) mice. Atherogenesis involves both inflammation and lipid deposition, and we investigated the role of SP-D in the development of atherosclerosis. SP-D synthesis was localized to vascular endothelial cells. Atherosclerotic lesion areas were 5.6-fold smaller in the aortic roots in Spd-/- mice compared with wild-type C57BL/6N mice on an atherogenic diet. HDL cholesterol (HDL-C) was significantly elevated in Spd-/- mice. Treatment of Spd-/- mice with a recombinant fragment of human SP-D resulted in decreases of HDL-C (21%) as well as total cholesterol (26%), and LDL cholesterol (28%). Plasma TNF-α was reduced in Spd-/- mice (45% difference). SP-D was proatherogenic in the mouse model used. The effect is likely to be due to the observed disturbances of plasma lipid metabolism and alteration of the inflammatory process, which underlie the reduced susceptibility to atherosclerosis in Spd-/- mice.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume290
Issue number6
DOIs
StatePublished - Jun 2006

Fingerprint

Pulmonary Surfactant-Associated Protein D
Atherosclerosis
HDL Cholesterol
Atherogenic Diet
Lipids
Inbred C57BL Mouse
Lipid Metabolism
LDL Cholesterol

Keywords

  • Atherosclerosis
  • Experimental animals
  • High-density lipoprotein
  • Tumor necrosis factor-α

ASJC Scopus subject areas

  • Physiology

Cite this

Sorensen, G. L., Madsen, J., Kejling, K., Tornoe, I., Nielsen, O., Townsend, P., ... Holmskov, U. (2006). Surfactant protein D is proatherogenic in mice. American Journal of Physiology - Heart and Circulatory Physiology, 290(6). https://doi.org/10.1152/ajpheart.01105.2005

Surfactant protein D is proatherogenic in mice. / Sorensen, Grith L.; Madsen, Jens; Kejling, Karin; Tornoe, Ida; Nielsen, Ole; Townsend, Paul; Poulain, Francis R; Nielsen, Claus H.; Reid, Kenneth B M; Hawgood, Samuel; Falk, Erling; Holmskov, Uffe.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 290, No. 6, 06.2006.

Research output: Contribution to journalArticle

Sorensen, GL, Madsen, J, Kejling, K, Tornoe, I, Nielsen, O, Townsend, P, Poulain, FR, Nielsen, CH, Reid, KBM, Hawgood, S, Falk, E & Holmskov, U 2006, 'Surfactant protein D is proatherogenic in mice', American Journal of Physiology - Heart and Circulatory Physiology, vol. 290, no. 6. https://doi.org/10.1152/ajpheart.01105.2005
Sorensen, Grith L. ; Madsen, Jens ; Kejling, Karin ; Tornoe, Ida ; Nielsen, Ole ; Townsend, Paul ; Poulain, Francis R ; Nielsen, Claus H. ; Reid, Kenneth B M ; Hawgood, Samuel ; Falk, Erling ; Holmskov, Uffe. / Surfactant protein D is proatherogenic in mice. In: American Journal of Physiology - Heart and Circulatory Physiology. 2006 ; Vol. 290, No. 6.
@article{3f9cbff97698451484063048cb879c1f,
title = "Surfactant protein D is proatherogenic in mice",
abstract = "Surfactant protein D (SP-D) is an important innate immune defense molecule that mediates clearance of pathogens and modulates the inflammatory response. Moreover, SP-D is involved in lipid homeostasis, and pulmonary accumulation of phospholipids has previously been observed in SP-D-deficient (Spd-/-) mice. Atherogenesis involves both inflammation and lipid deposition, and we investigated the role of SP-D in the development of atherosclerosis. SP-D synthesis was localized to vascular endothelial cells. Atherosclerotic lesion areas were 5.6-fold smaller in the aortic roots in Spd-/- mice compared with wild-type C57BL/6N mice on an atherogenic diet. HDL cholesterol (HDL-C) was significantly elevated in Spd-/- mice. Treatment of Spd-/- mice with a recombinant fragment of human SP-D resulted in decreases of HDL-C (21{\%}) as well as total cholesterol (26{\%}), and LDL cholesterol (28{\%}). Plasma TNF-α was reduced in Spd-/- mice (45{\%} difference). SP-D was proatherogenic in the mouse model used. The effect is likely to be due to the observed disturbances of plasma lipid metabolism and alteration of the inflammatory process, which underlie the reduced susceptibility to atherosclerosis in Spd-/- mice.",
keywords = "Atherosclerosis, Experimental animals, High-density lipoprotein, Tumor necrosis factor-α",
author = "Sorensen, {Grith L.} and Jens Madsen and Karin Kejling and Ida Tornoe and Ole Nielsen and Paul Townsend and Poulain, {Francis R} and Nielsen, {Claus H.} and Reid, {Kenneth B M} and Samuel Hawgood and Erling Falk and Uffe Holmskov",
year = "2006",
month = "6",
doi = "10.1152/ajpheart.01105.2005",
language = "English (US)",
volume = "290",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Surfactant protein D is proatherogenic in mice

AU - Sorensen, Grith L.

AU - Madsen, Jens

AU - Kejling, Karin

AU - Tornoe, Ida

AU - Nielsen, Ole

AU - Townsend, Paul

AU - Poulain, Francis R

AU - Nielsen, Claus H.

AU - Reid, Kenneth B M

AU - Hawgood, Samuel

AU - Falk, Erling

AU - Holmskov, Uffe

PY - 2006/6

Y1 - 2006/6

N2 - Surfactant protein D (SP-D) is an important innate immune defense molecule that mediates clearance of pathogens and modulates the inflammatory response. Moreover, SP-D is involved in lipid homeostasis, and pulmonary accumulation of phospholipids has previously been observed in SP-D-deficient (Spd-/-) mice. Atherogenesis involves both inflammation and lipid deposition, and we investigated the role of SP-D in the development of atherosclerosis. SP-D synthesis was localized to vascular endothelial cells. Atherosclerotic lesion areas were 5.6-fold smaller in the aortic roots in Spd-/- mice compared with wild-type C57BL/6N mice on an atherogenic diet. HDL cholesterol (HDL-C) was significantly elevated in Spd-/- mice. Treatment of Spd-/- mice with a recombinant fragment of human SP-D resulted in decreases of HDL-C (21%) as well as total cholesterol (26%), and LDL cholesterol (28%). Plasma TNF-α was reduced in Spd-/- mice (45% difference). SP-D was proatherogenic in the mouse model used. The effect is likely to be due to the observed disturbances of plasma lipid metabolism and alteration of the inflammatory process, which underlie the reduced susceptibility to atherosclerosis in Spd-/- mice.

AB - Surfactant protein D (SP-D) is an important innate immune defense molecule that mediates clearance of pathogens and modulates the inflammatory response. Moreover, SP-D is involved in lipid homeostasis, and pulmonary accumulation of phospholipids has previously been observed in SP-D-deficient (Spd-/-) mice. Atherogenesis involves both inflammation and lipid deposition, and we investigated the role of SP-D in the development of atherosclerosis. SP-D synthesis was localized to vascular endothelial cells. Atherosclerotic lesion areas were 5.6-fold smaller in the aortic roots in Spd-/- mice compared with wild-type C57BL/6N mice on an atherogenic diet. HDL cholesterol (HDL-C) was significantly elevated in Spd-/- mice. Treatment of Spd-/- mice with a recombinant fragment of human SP-D resulted in decreases of HDL-C (21%) as well as total cholesterol (26%), and LDL cholesterol (28%). Plasma TNF-α was reduced in Spd-/- mice (45% difference). SP-D was proatherogenic in the mouse model used. The effect is likely to be due to the observed disturbances of plasma lipid metabolism and alteration of the inflammatory process, which underlie the reduced susceptibility to atherosclerosis in Spd-/- mice.

KW - Atherosclerosis

KW - Experimental animals

KW - High-density lipoprotein

KW - Tumor necrosis factor-α

UR - http://www.scopus.com/inward/record.url?scp=33744931099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744931099&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.01105.2005

DO - 10.1152/ajpheart.01105.2005

M3 - Article

C2 - 16387789

AN - SCOPUS:33744931099

VL - 290

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 6

ER -